← Back to headlines
Biotech Fund Sells Nuvalent Shares After 29% Stock Surge
A biotech fund has divested $84 million worth of Nuvalent shares, despite the stock experiencing a 29% increase.
23 Feb, 15:21 — 23 Feb, 15:21
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Strategy shows no fear — it keeps adding to a losing bitcoin position as prices drop
15m ago
Call for Affordable Banking Services for Small Associations
22m ago
Stock market extends losses as investors grapple with tariff uncertainty
24m ago
Nvidia, Salesforce, and Snowflake Earnings to Impact S&P 500
24m ago